Literature DB >> 20373339

Chronic cerebrospinal venous insufficiency and multiple sclerosis.

Omar Khan1, Massimo Filippi, Mark S Freedman, Frederik Barkhof, Paula Dore-Duffy, Hans Lassmann, Bruce Trapp, Amit Bar-Or, Imad Zak, Marilyn J Siegel, Robert Lisak.   

Abstract

A chronic state of impaired venous drainage from the central nervous system, termed chronic cerebrospinal venous insufficiency (CCSVI), is claimed to be a pathologic phenomenon exclusively seen in multiple sclerosis (MS). This has invigorated the causal debate of MS and generated immense interest in the patient and scientific communities. A potential shift in the treatment paradigm of MS involving endovascular balloon angioplasty or venous stent placement has been proposed as well as conducted in small patient series. In some cases, it may have resulted in serious injury. In this Point of View, we discuss the recent investigations that led to the description of CCSVI as well as the conceptual and technical shortcomings that challenge the potential relationship of this phenomenon to MS. The need for conducting carefully designed and rigorously controlled studies to investigate CCVSI has been recognized by the scientific bodies engaged in MS research. Several scientific endeavors examining the presence of CCSVI in MS are being undertaken. At present, invasive and potentially dangerous endovascular procedures as therapy for patients with MS should be discouraged until such studies have been completed, analyzed, and debated in the scientific arena.

Entities:  

Mesh:

Year:  2010        PMID: 20373339     DOI: 10.1002/ana.22001

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  31 in total

1.  Chronic cerebrospinal venous insufficiency: does ultrasound really distinguish multiple sclerosis subjects from healthy controls?

Authors:  Fatih Kantarci; Sait Albayram; Nuri Onat Demirci; Asim Esenkaya; Derya Uluduz; Omer Uysal; Sabahattin Saip; Aksel Siva
Journal:  Eur Radiol       Date:  2011-11-29       Impact factor: 5.315

2.  Chronic cerebrospinal venous insufficiency in multiple sclerosis: a historical perspective.

Authors:  Michael D Dake; Robert Zivadinov; E Mark Haacke
Journal:  Funct Neurol       Date:  2011 Oct-Dec

3.  Venous angioplasty in multiple sclerosis: neurological outcome at two years in a cohort of relapsing-remitting patients.

Authors:  Fabrizio Salvi; Ilaria Bartolomei; Elena Buccellato; Roberto Galeotti; Paolo Zamboni
Journal:  Funct Neurol       Date:  2012 Jan-Mar

4.  Chronic cerebrospinal venous insufficiency as a cause of multiple sclerosis: controversy and reality.

Authors:  Claudiu I Diaconu; Devon Conway; Robert J Fox; Alexander Rae-Grant
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

5.  Comparison of MR and contrast venography of the cervical venous system in multiple sclerosis.

Authors:  G Zaharchuk; N J Fischbein; J Rosenberg; R J Herfkens; M D Dake
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

6.  Multiple sclerosis: CCSVI deconstructed and discarded.

Authors:  Frederik Barkhof; Mike P Wattjes
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

7.  Multiple sclerosis and chronic cerebrospinal venous insufficiency: the neuroimaging perspective.

Authors:  M Filippi; M A Rocca; F Barkhof; R Bakshi; F Fazekas; O Khan; D Pelletier; A Rovira; J Simon
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-03       Impact factor: 3.825

8.  Comment on: Use of MR Venography for Characterization of the Extracranial Venous System in Patients with Multiple Sclerosis and Healthy Control Subjects : Zivadinov R, Lopez-Soriano A, Weinstock-Guttman B et al. Radiology. 2011;258:562-70.

Authors:  Kira Lutz; Alexander Radbruch; Martin Bendszus
Journal:  Clin Neuroradiol       Date:  2011-04       Impact factor: 3.649

9.  Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis.

Authors:  Vanitha A Jagannath; Eugenio Pucci; Govindaraj V Asokan; Edward W Robak
Journal:  Cochrane Database Syst Rev       Date:  2019-05-31

10.  Phlebographic study does not show differences between patients with MS and control subjects.

Authors:  M Stefanini; S Fabiano; F Garaci; S Marziali; A Meschini; V Cama; M Fornari; S Rossi; D Centonze; R Gandini; G Simonetti; R Floris
Journal:  AJNR Am J Neuroradiol       Date:  2014-02-13       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.